期刊文献+

mdr1及P-gP与脑胶质瘤耐药关系的研究 被引量:1

下载PDF
导出
摘要 恶性胶质瘤患者平均生存期较短,通常手术切除肿瘤组织并不能从根本上延长患者的生存时间,而且应用药物化疗易产生多药耐药性(multidrug resistance,MDR),使化疗失败。P-糖蛋白(P-glycoprotein,P-gp)和多药耐药相关蛋白(multidrug resistance associated protein,MRP)介导的药物外排是产生MDR的主要机制,其编码基因分别为mdr1和 mrp1。
出处 《天津医药》 CAS 北大核心 2011年第2期169-170,共2页 Tianjin Medical Journal
  • 相关文献

参考文献6

二级参考文献46

  • 1Labialle S, GayetL, Marthinet E, et al. Transcriptional regulators of the human muhidrug resistance 1 gene: recent views [ J ]. Biochem Pharmacol, 2002, 64 ( 5 - 6 ) : 943 - 948.
  • 2Comerford KM, Wallace TJ, Karhausen J, et al. Hypoxia-inducible factor-1 - dependent regulation of the muhidrug resistance ( MDR1 ) gene [J]. Cancer Res, 2002, 62( 12): 3387-3394.
  • 3Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumor [ J]. Cancer Res, 2003, 63 (18) : 5821 - 5828.
  • 4Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma [ J ]. Cancer Res, 2004, 64( 19): 7011 -7021.
  • 5Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors [ J]. Proc Natl Acad Sci USA, 2003, 100(25) : 15178 -15183.
  • 6Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi) [J]. FEBSLett, 2003, 545(2-3): 144 -150.
  • 7Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells [ J]. Science, 2002, 296(5567) : 550-553.
  • 8Paus C, Murat A, Stupp R, et al. Role of MGMT and clinical applications in brain tumors [J]. J Bull Cancer, 2007, 94(9): 769-773.
  • 9Ostrowski IrE, von Wronski MA, Bigner SH, et al. Expression of 06-methylguanine-DNA methyltransferase in malignant human glioma cell lines [J]. Carcinogenesis, 1991, 12 (9): 1739-1744.
  • 10Hegi ME, Liu L, Herman JG, et al. Correlation of O6-methylguanine methyhransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity [J]. J Clin Oneol, 2008, 26 (25): 4189-4199.

共引文献17

同被引文献16

  • 1Andratachke N, Grosu AL, Molls M, et al. Perspectives in the treatment of malignant gliomas in adults [J]. Anticancer Res, 2001, 21(5): 3541-3550.
  • 2Cianfriglia M. The biology of MDR1-P-glycoprotein (MDR1-Pgp) in designing functional antibody drug conjugates (ADCs): the experience ofgemtuzumab ozogamicin [J]. Ann Ist Super Sanita, 2013, 49(2): 150-168. DO1:10.4415/ANN 13 02 07.
  • 3Dean M, Fojo T, Bates S. Tumor stem cells and drug resistance[J]. Nat Rev Cancer, 2005, 5(4): 275-284. DO1:10.1038/nrc1590.
  • 4Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters [J]. Nature, 2007, 446: 749-757. DOI: 10.1038/nature05630.
  • 5Debska S, Owecka A, Czernek U, et al. Transmembrane transporters ABCC-structure, function and role in muhidrug resistance of cancer cells [J]. Postepy I-lig Med Dosw (Online), 2011, 65: 552-561. DOI: 10.5604/17322693.956500.
  • 6Remer S, Murphy ME. The challenges of long-term treatment outcomes in adults with malignant gliomas [J]. Clio J Oncol Nuts, 2004, 8(4): 368-376, DOI: 10.1188/04.CJON.368-376.
  • 7Nakagawa T, Ido K, Sakuma T, et al. Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas [J]. Neuropathology, 2009, 29 (4): 379-388. DOI: 10.111 i/j.1440-1789.2008.00983.x.
  • 8Krishnamachary N, Center MS. The MRP gene associated with a non-pglycoprotein multidrug resistance encodes a 190-KDa membrane bound glycoprotein [J]. Cancer Res, 1993, 53 (7): 3658-3662.
  • 9Bader P, Schilling F, Schlaud M, et al. Expression analysis of multidrug resistance associateed genes in neuroblastomas[J]. Oncol Rep, 1999, 6(5): 1143. DOI: 10.3892/or.6.5.1143.
  • 10Faria GP, O liveira JA, O liveira JG, et al. Differences in the expression pattern of P-glycoprotein and MRP1 in low-grade and high-grade gliomas[J]. Cancer Invest, 2008, 26(9): 883-889. DOI: 10.1080/07357900801975264.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部